Lucia Cannella
Overview
Explore the profile of Lucia Cannella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pagliuca F, Carraturo E, De Chiara A, Vallese S, Giovannoni I, Alaggio R, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000489
Synovial sarcomas are soft tissue tumours of uncertain origin, most commonly found in the upper or lower extremities. They are characterised by distinctive chromosomal rearrangements involving the gene . Synovial...
2.
Bracigliano A, Marretta A, Guerrera L, Simioli R, Clemente O, Granata V, et al.
Pharmaceuticals (Basel)
. 2024 Mar;
17(3).
PMID: 38543140
Pheochromocytomas (PCCs) and Paragangliomas (PGLs), commonly known as PPGLs to include both entities, are rare neuroendocrine tumors that may arise in the context of hereditary syndromes or be sporadic. However,...
3.
Fiorelli A, Cannella L, Capasso F, Pizzolorusso A, Picozzi F, Messina G, et al.
Thorac Cancer
. 2023 Aug;
14(26):2712-2714.
PMID: 37555456
Complex persistent air leak (PAL) is a clinical condition which is difficult to treat. Herein, we report the clinical case of an 18-year-old woman with lung and bone metastases due...
4.
Cannella L, Della Monica R, Marretta A, Iervolino D, Vincenzi B, De Chiara A, et al.
Cells
. 2023 Jun;
12(12).
PMID: 37371106
Dacarbazine is an important drug in the therapeutic landscape of leiomyosarcoma (LMS). Alkylating agents are subjected to resistance mechanisms based on anti-apoptotic pathways and repair mechanisms, including the DNA repair...
5.
Cannella L, Perri F, Clemente O, von Arx C, Pizzolorusso A, di Bonito M, et al.
Oncology
. 2022 Dec;
101(4):234-239.
PMID: 36538913
Background/aim: Breast angiosarcoma is a rare and aggressive disease with a poor prognosis. Two subtypes have been identified: primary angiosarcoma (PBA) and secondary breast angiosarcoma (SBA). In this retrospective analysis,...
6.
Marretta A, Di Lorenzo G, Ribera D, Cannella L, von Arx C, Bracigliano A, et al.
Pharmaceutics
. 2021 Sep;
13(9).
PMID: 34575598
Nucleocytoplasmic transport has been found dysregulated in many types of cancer and is often described as a poor prognostic factor. Specifically, Exportin-1 (XPO1) has been found overexpressed in many tumors...
7.
Multidisciplinary Management of Retroperitoneal Sarcoma: Diagnosis, Prognostic Factors and Treatment
Carbone F, Pizzolorusso A, Di Lorenzo G, Di Marzo M, Cannella L, Barretta M, et al.
Cancers (Basel)
. 2021 Aug;
13(16).
PMID: 34439171
Retroperitoneal sarcomas (RPS) are rare cancers whose management can be challenging due to various presentation patterns, multiple organ involvement, and a high local and distant recurrence rate. Histopathology and prognostic...
8.
Minopoli M, Sarno S, Cannella L, Tafuto S, Scognamiglio G, Gallo M, et al.
Cancers (Basel)
. 2021 Jul;
13(13).
PMID: 34209309
Myxoid liposarcoma (MLPS) is the second most common subtype of liposarcoma and has tendency to metastasize to soft tissues. To date, the mechanisms of invasion and metastasis of MLPS remain...
9.
Clemente O, Ottaiano A, Di Lorenzo G, Bracigliano A, Lamia S, Cannella L, et al.
J Transl Med
. 2021 Apr;
19(1):173.
PMID: 33902630
Sarcomas are rare, ubiquitous and heterogeneous tumors usually treated with surgery, chemotherapy, target therapy, and radiotherapy. However, 25-50% of patients experience local relapses and/or distant metastases after chemotherapy with an...
10.
Isgro M, Vitale M, Celentano E, Nocerino F, Porciello G, Curvietto M, et al.
J Transl Med
. 2021 Apr;
19(1):132.
PMID: 33789686
Coronavirus disease 2019 (COVID-19) global pandemic has created unique challenges to healthcare systems throughout the world. Ensuring subjects' safety is mandatory especially in oncology, in consideration of cancer patients' particular...